ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that it plans to issue its financial results for the fourth quarter ended December 31, 2008 on February 11 after the close of the stock market. Management will conduct a conference call on Thursday, February 12 at 8:30 a.m. Eastern Time to discuss these results.
